ERN background

Why rare diseases?

20 Feb 2019

Between 5 000 and 8 000 rare diseases affect the daily lives of around 30 million people in the EU. For example, in the field of oncology alone, there …


Recent activities

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

6 Apr 2020

The New England Journal of Medicine have recently published this special report on Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Co …


The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern